Aiming to discover new disease modifying treatments and working towards a cure for Parkinson's disease.

Summary

The Company’s primary objective is the discovery of drugs that can prevent or inhibit the progression of Parkinson’s disease. The Company’s primary goal is to discover and co-develop drugs that stop the disease progression and the Company also aims to exploit any new drugs that lead to the improvement of symptoms.   The Company uses an in-vivo (i.e. in living tissue rather than test tubes) drug discovery platform.

Product

Life Sciences SEIS

Sector

Drug discovery

Status

Closed

HMRC

Advanced Assurance

Company Website

http://parkure.co.uk/